Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Pormedtec Co. Ltd. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and various art units. This distribution shows that the company's current applications are being reviewed by different specialized units within the patent office, which may result in independent prosecution tracks. The presence of the 2 pending office actions across the various units indicates a spread of technical focus within the biotechnology sector.
Tracy Ann Vivlemore is the busiest examiner for the portfolio, with 1 pending office action. Since there are several pending actions in total, the workload is split, with Tracy Ann Vivlemore handling 1 of the company's active office action responses. Practitioners should monitor the specific feedback from Tracy Ann Vivlemore, as her review of the action is a major component of the current prosecution effort. The progress of this case will significantly impact the company's overall patent position.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.4% |
| GRAY, JESSICA | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17502344 | METHOD FOR TESTING XENOTRANSPLANTATION MATERIAL FOR PATHOGEN INFECTION, TEST KIT, AND METHOD FOR PRODUCING XENOTRANSPLANTATION MATERIAL PRODUCT WHICH HAS BEEN EVALUATED FOR PATHOGEN INFECTION | GRAY, JESSICA | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18725479 | METHOD FOR PRODUCING TRANSPLANT MATERIAL, AND TRANSPLANT MATERIAL | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 17502344 | METHOD FOR TESTING XENOTRANSPLANTATION MATERIAL FOR PATHOGEN INFECTION, TEST KIT, AND METHOD FOR PRODUCING XENOTRANSPLANTATION MATERIAL PRODUCT WHICH HAS BEEN EVALUATED FOR PATHOGEN INFECTION | GRAY, JESSICA | 1682 | §103§112 | Final Rejection | 4d overdue | Pending | Oct 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPormedtec Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Tracy Ann Vivlemore has the most, with 1 of Pormedtec Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
